Viewing StudyNCT00225979



Ignite Creation Date: 2024-05-05 @ 12:03 PM
Last Modification Date: 2024-10-26 @ 9:19 AM
Study NCT ID: NCT00225979
Status: COMPLETED
Last Update Posted: 2012-04-11
First Post: 2005-09-23

Brief Title: Safety and Efficacy of Long-acting Repeatable Octreotide Acetate for Injectable Suspension vs Surgery in Treatment-naïve Patients With Acromegaly
Sponsor: Novartis Pharmaceuticals
Organization: Novartis

Conditions & Keywords Data

Conditions:
Name
Acromegaly
Keywords:
Name View
Acromegaly View
Untreated View
Newly diagnosed View
Octreotide LAR View
Pituitary surgery View